Westlake Chemical Partners LP Announces Third Quarter 2025 Results

  • Renewed Ethylene Sales Agreement through 2027 at existing terms
  • Declared quarterly distribution of $0.4714 per unit; 45th consecutive quarterly distribution

Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2025 of $14.7 million, or $0.42 per limited partner unit, which was below third quarter 2024 net income of $18.1 million. Cash flows from operating activities in the third quarter of 2025 were $105.2 million, a decrease of $20.9 million compared to third quarter 2024 cash flows from operating activities of $126.1 million. For the three months ended September 30, 2025, MLP distributable cash flow was $14.9 million, a decrease of $3.0 million compared to third quarter 2024 MLP distributable cash flow of $17.9 million. The decrease in MLP distributable cash flow and associated trailing twelve-month coverage ratio was primarily due to higher maintenance capital expenditures.

Third quarter 2025 net income attributable to the Partnership of $14.7 million was in line with net income attributable to the Partnership of $14.6 million in the second quarter of 2025. Third quarter 2025 cash flows from operating activities of $105.2 million increased by $96.1 million compared to second quarter 2025 cash flows from operating activities of $9.1 million due to a significant decline in cash payments related to the Petro 1 turnaround, which was completed in the second quarter of 2025. Third quarter 2025 MLP distributable cash flow of $14.9 million was in line with second quarter 2025 MLP distributable cash flow of $15.0 million.

"During the third quarter of 2025, OpCo's assets ran well and production returned to nameplate capacity levels following the completion of the planned Petro 1 turnaround in the first half of the year. While spot ethylene prices declined throughout the third quarter, there was minimal impact on the Partnership's cash flows due to the Ethylene Sales Agreement with Westlake that provides a predictable, fee-based cash flow structure with take-or-pay protections for 95% of OpCo's production," said Jean-Marc Gilson, President and Chief Executive Officer. "Given its importance to the stability and predictability of the Partnership's cash flows, we were pleased that OpCo renewed the Ethylene Sales Agreement with Westlake earlier this week with no changes to the contract's terms or conditions. We look forward to continuing our mutually-beneficial relationship with Westlake for years to come."

On October 28, 2025, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the third quarter of 2025 of $0.4714 per common unit to be payable on November 26, 2025 to unitholders of record as of November 10, 2025, representing the 45th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage that was 0.75x the declared distributions for the third quarter of 2025, which was below the trailing twelve-month coverage ratio of 0.79x at the end of the second quarter of 2025 due to the timing of maintenance capital expenditures. Since our IPO in July of 2014 our cumulative coverage ratio is approximately 1.05x.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the results of future turnarounds, our expectations regarding the amount and timing of future capital expenditures, the ability to deliver value, returns, predictable cash flows and distributions to unitholders, our relationship with Westlake and the benefits of the ethylene sales agreement with Westlake, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, pandemic infectious diseases and the response thereto; operating disruptions, including delays in turnaround activities; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including the renewal or renegotiation of, or determinations made pursuant to, our contractual arrangements with Westlake; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC in March 2025, and the Partnership's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, which was filed with the SEC in August 2025.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' third quarter 2025 results will be held Thursday, October 30th 2025 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI18a27e98796e4538920bcc251d12d94a. A dial-in will be provided upon registration.

The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/zo2bvgiu and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.

 

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

(In thousands of dollars, except per unit data)

Revenue

 

 

 

 

 

 

 

 

Net sales—Westlake Corporation ("Westlake")

 

$

276,539

 

 

$

215,799

 

 

$

736,396

 

 

$

690,535

 

Net co-products, ethylene and other sales—third parties

 

 

32,359

 

 

 

61,196

 

 

 

107,250

 

 

 

155,301

 

Total net sales

 

 

308,898

 

 

 

276,995

 

 

 

843,646

 

 

 

845,836

 

Cost of sales

 

 

209,475

 

 

 

160,052

 

 

 

592,610

 

 

 

525,481

 

Gross profit

 

 

99,423

 

 

 

116,943

 

 

 

251,036

 

 

 

320,355

 

Selling, general and administrative expenses

 

 

7,444

 

 

 

7,254

 

 

 

21,218

 

 

 

21,936

 

Income from operations

 

 

91,979

 

 

 

109,689

 

 

 

229,818

 

 

 

298,419

 

Other income (expense)

 

 

 

 

 

 

 

 

Interest expense—Westlake

 

 

(5,947

)

 

 

(6,698

)

 

 

(17,391

)

 

 

(19,930

)

Other income, net

 

 

224

 

 

 

1,325

 

 

 

2,245

 

 

 

3,916

 

Income before income taxes

 

 

86,256

 

 

 

104,316

 

 

 

214,672

 

 

 

282,405

 

Provision for income taxes

 

 

42

 

 

 

216

 

 

 

354

 

 

 

633

 

Net income

 

 

86,214

 

 

 

104,100

 

 

 

214,318

 

 

 

281,772

 

Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")

 

 

71,561

 

 

 

85,964

 

 

 

180,159

 

 

 

234,376

 

Net income attributable to Westlake Partners

 

$

14,653

 

 

$

18,136

 

 

$

34,159

 

 

$

47,396

 

 

 

 

 

 

 

 

 

 

Net income per limited partner unit attributable to Westlake Partners (basic and diluted)

 

 

 

 

 

 

 

 

Common units

 

$

0.42

 

 

$

0.51

 

 

$

0.97

 

 

$

1.35

 

 

 

 

 

 

 

 

 

 

Distributions declared per unit

 

$

0.4714

 

 

$

0.4714

 

 

$

1.4142

 

 

$

1.4142

 

 

 

 

 

 

 

 

 

 

MLP distributable cash flow

 

$

14,886

 

 

$

17,879

 

 

$

34,607

 

 

$

51,906

 

 

 

 

 

 

 

 

 

 

Distributions declared

 

 

 

 

 

 

 

 

Limited partner units—publicly and privately held

 

$

9,958

 

 

$

9,954

 

 

$

29,867

 

 

$

29,855

 

Limited partner units—Westlake

 

 

6,657

 

 

 

6,657

 

 

 

19,971

 

 

 

19,971

 

Total distributions declared

 

$

16,615

 

 

$

16,611

 

 

$

49,838

 

 

$

49,826

 

EBITDA

 

$

126,075

 

 

$

139,126

 

 

$

325,487

 

 

$

386,756

 

 

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

September 30,

2025

 

December 31,

2024

 

 

(In thousands of dollars)

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

37,936

 

 

$

58,316

 

Receivable under the Investment Management Agreement—Westlake

 

 

13,396

 

 

 

134,557

 

Accounts receivable, net—Westlake

 

 

59,665

 

 

 

31,975

 

Accounts receivable, net—third parties

 

 

16,141

 

 

 

11,576

 

Inventories

 

 

3,078

 

 

 

4,058

 

Prepaid expenses and other current assets

 

 

641

 

 

 

444

 

Total current assets

 

 

130,857

 

 

 

240,926

 

Property, plant and equipment, net

 

 

902,813

 

 

 

903,588

 

Other assets, net

 

 

237,943

 

 

 

143,442

 

Total assets

 

$

1,271,613

 

 

$

1,287,956

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

Current liabilities (accounts payable and accrued and other liabilities)

 

$

55,126

 

 

$

55,372

 

Long-term debt payable to Westlake

 

 

399,674

 

 

 

399,674

 

Other liabilities

 

 

3,502

 

 

 

3,596

 

Total liabilities

 

 

458,302

 

 

 

458,642

 

Common unitholders—publicly and privately held

 

 

462,093

 

 

 

471,328

 

Common unitholder—Westlake

 

 

41,091

 

 

 

47,373

 

General partner—Westlake

 

 

(242,572

)

 

 

(242,572

)

Total Westlake Partners partners' capital

 

 

260,612

 

 

 

276,129

 

Noncontrolling interest in OpCo

 

 

552,699

 

 

 

553,185

 

Total equity

 

 

813,311

 

 

 

829,314

 

Total liabilities and equity

 

$

1,271,613

 

 

$

1,287,956

 

 

WESTLAKE CHEMICAL PARTNERS LP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2024

 

 

 

(In thousands of dollars)

Cash flows from operating activities

 

 

 

 

Net income

 

$

214,318

 

 

$

281,772

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

Depreciation and amortization

 

 

93,424

 

 

 

84,421

 

Net loss on disposition and other

 

 

2,371

 

 

 

2,227

 

Other balance sheet changes

 

 

(150,023

)

 

 

(15,888

)

Net cash provided by operating activities

 

 

160,090

 

 

 

352,532

 

Cash flows from investing activities

 

 

 

 

Additions to property, plant and equipment

 

 

(69,988

)

 

 

(35,497

)

Investments with Westlake under the Investment Management Agreement

 

 

 

 

 

(15,000

)

Maturities of investments with Westlake under the Investment Management Agreement

 

 

120,000

 

 

 

 

Net cash provided by (used for) investing activities

 

 

50,012

 

 

 

(50,497

)

Cash flows from financing activities

 

 

 

 

Proceeds from debt payable to Westlake

 

 

135,000

 

 

 

163,000

 

Repayment of debt payable to Westlake

 

 

(135,000

)

 

 

(163,000

)

Distributions to noncontrolling interest retained in OpCo by Westlake

 

 

(180,645

)

 

 

(250,622

)

Distributions to unitholders

 

 

(49,837

)

 

 

(49,824

)

Net cash used for financing activities

 

 

(230,482

)

 

 

(300,446

)

Net increase (decrease) in cash and cash equivalents

 

 

(20,380

)

 

 

1,589

 

Cash and cash equivalents at beginning of period

 

 

58,316

 

 

 

58,619

 

Cash and cash equivalents at end of period

 

$

37,936

 

 

$

60,208

 

 

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months Ended June 30,

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

9,071

 

 

$

105,238

 

 

$

126,071

 

 

$

160,090

 

 

$

352,532

 

Changes in operating assets and liabilities and other

 

 

76,724

 

 

 

(19,024

)

 

 

(21,971

)

 

 

54,228

 

 

 

(70,760

)

Net income

 

 

85,795

 

 

 

86,214

 

 

 

104,100

 

 

 

214,318

 

 

 

281,772

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation, amortization and disposition of property, plant and equipment

 

 

32,872

 

 

 

35,660

 

 

 

28,528

 

 

 

95,703

 

 

 

86,662

 

Less:

 

 

 

 

 

 

 

 

 

 

Contribution to turnaround reserves

 

 

(10,396

)

 

 

(10,486

)

 

 

(11,903

)

 

 

(28,504

)

 

 

(32,051

)

Maintenance capital expenditures

 

 

(20,506

)

 

 

(24,150

)

 

 

(17,753

)

 

 

(65,233

)

 

 

(34,808

)

Distributable cash flow attributable to noncontrolling interest in OpCo

 

 

(72,758

)

 

 

(72,352

)

 

 

(85,093

)

 

 

(181,677

)

 

 

(249,669

)

MLP distributable cash flow

 

$

15,007

 

 

$

14,886

 

 

$

17,879

 

 

$

34,607

 

 

$

51,906

 

 

WESTLAKE CHEMICAL PARTNERS LP

RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months Ended June 30,

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2025

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

9,071

 

 

$

105,238

 

 

$

126,071

 

 

$

160,090

 

 

$

352,532

 

Changes in operating assets and liabilities and other

 

 

76,724

 

 

 

(19,024

)

 

 

(21,971

)

 

 

54,228

 

 

 

(70,760

)

Net income

 

 

85,795

 

 

 

86,214

 

 

 

104,100

 

 

 

214,318

 

 

 

281,772

 

Less:

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

675

 

 

 

224

 

 

 

1,325

 

 

 

2,245

 

 

 

3,916

 

Interest expense—Westlake

 

 

(5,907

)

 

 

(5,947

)

 

 

(6,698

)

 

 

(17,391

)

 

 

(19,930

)

Provision for income taxes

 

 

(205

)

 

 

(42

)

 

 

(216

)

 

 

(354

)

 

 

(633

)

Income from operations

 

 

91,232

 

 

 

91,979

 

 

 

109,689

 

 

 

229,818

 

 

 

298,419

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

32,484

 

 

 

33,872

 

 

 

28,112

 

 

 

93,424

 

 

 

84,421

 

Other income, net

 

 

675

 

 

 

224

 

 

 

1,325

 

 

 

2,245

 

 

 

3,916

 

EBITDA

 

$

124,391

 

 

$

126,075

 

 

$

139,126

 

 

$

325,487

 

 

$

386,756

 

 

Contacts

Contact—(713) 585-2900

Investors—Steve Bender

Media—L. Benjamin Ederington

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.86
+0.00 (0.00%)
AAPL  271.40
+0.00 (0.00%)
AMD  254.84
+0.00 (0.00%)
BAC  53.03
+0.00 (0.00%)
GOOG  281.90
+0.00 (0.00%)
META  666.47
+0.00 (0.00%)
MSFT  525.76
+0.00 (0.00%)
NVDA  202.89
+0.00 (0.00%)
ORCL  256.89
+0.00 (0.00%)
TSLA  440.10
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.